Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
Fatigue-Biomedicine Health and Behavior
ISSN 2164-1846 · eISSN 2164-1862 · Taylor & Francis
Fatigue-Biomedicine Health and Behavior: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.4 (journal website); hybrid open access; APC about USD 3,250; median 119 days to acceptance (46 articles, last 24 months); acceptance rate 35% (journal website); 31 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Fatigue-Biomedicine Health and Behavior is published by Taylor & Francis and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Fibromyalgia and Chronic Fatigue Syndrome Research, Psychosomatic Disorders and Their Treatments and Health, psychology, and well-being, together about 49.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Fatigue: Biomedicine, Health and Behavior is an international, interdisciplinary journal that addresses the symptom of fatigue in medical illnesses, behavioral disorders, and specific environmental conditions. These broadly conceived domains, all housed in one journal, are intended to advance research on causation, pathophysiology, assessment, and treatment. The content that we seek includes original research papers, literature reviews, meta-analyses, data-based theoretical papers, short reports, qualitative studies, innovative case studies, conference reports, expert interactive commentary, and letters to the editor. The list of topics covered in Fatigue will include fatigue in diseases including cancer, autoimmune diseases, multiple sclerosis, pain conditions, mood disorders, and circulatory diseases. The journal will also publish papers on chronic fatigue syndrome, fibromyalgia and related illnesses. In addition, submissions on specific issues involving fatigue in sleep, aging, exercise and sport, and occupations are welcomed. More generally, the journal will publish on the biology, physiology and psychosocial aspects of fatigue. The Editor also welcomes new topics such as clinical fatigue education in medical schools and public health policy with respect to fatigue. Article Types Considered for Publication Fatigue considers a number of different article types in addition to regular articles, including Short Reports, Reviews, Case Studies, Commentaries, and more. For more information on the types of manuscripts considered for publication click here. Audience Physicians, research scientists, psychologists, nurses, physical and occupational therapists, and other health researchers and clinicians who value knowledge of fatigue as an important factor in illness, aging, sleep, occupations, and exercise and athletics. Peer Review Integrity All research articles in this journal, including those in special issues, special sections or supplements, undergo rigorous peer review, based on initial editor screening and anonymized refereeing by at least two independent referees. Disclaimer
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Editorial board by country: none in mainland China; most named United States 7, United Kingdom 4, Australia 3, Netherlands 1, Belgium 1 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Fibromyalgia and Chronic Fatigue Syndrome ResearchMedicine34.7%
- Psychosomatic Disorders and Their TreatmentsMedicine8.8%
- Health, psychology, and well-beingHealth Professions6.4%
- Musculoskeletal pain and rehabilitationMedicine5.9%
- Genetic Neurodegenerative DiseasesNeuroscience5.7%
- Long-Term Effects of COVID-19Medicine4.3%
- Sleep and Work-Related FatiguePsychology4%
- Exercise and Physiological ResponsesMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 1.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.9Publisher website ·
- CiteScore 2026-06
- 3.1LetPub ·
- CiteScore (publisher) 2025
- 3.1Publisher website ·
- SJR 2026-06
- 0.56LetPub ·
- SJR (publisher) 2025
- 0.56Publisher website ·
- SNIP 2026-06
- 0.5LetPub ·
- SNIP (publisher) 2025
- 0.5Publisher website ·
- h-index
- 30OpenAlex ·
- i10-index
- 98OpenAlex ·
- 2-year mean citedness
- 1.08OpenAlex ·
- Self-citation rate
- 14.3%LetPub ·
- Share of gold OA articles
- 23.08%LetPub ·
Volume
- Articles per year
- 27LetPub ·
- Downloads per year (publisher)
- 65,000Publisher website ·
- Downloads per year (publisher) 2024
- 65,000Publisher website ·
Articles by year OpenAlex count · 306 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 22 | 9 | 8 |
| 2025 | 31 | 14 | 33 |
| 2024 | 22 | 8 | 40 |
| 2023 | 18 | 9 | 90 |
| 2022 | 19 | 8 | 194 |
| 2021 | 20 | 10 | 339 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
119 daysMedian, submission to acceptance · P25–P75 90 days – 168 days
- Acceptance to online
- median 15 days (46 articles)
- Submission to online
- median 135 days
- Sample
- 46 articles with submission and acceptance dates (56 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 35%Publisher website ·
- Acceptance rate (publisher) 2025
- 35%Publisher website ·
- Submission to first decision
- 66 daysPublisher website ·
- Submission to first decision 2025
- 66 daysPublisher website ·
- First decision after review
- 65 daysPublisher website ·
- First decision after review 2025
- 65 daysPublisher website ·
- Acceptance to publication
- 8 daysPublisher website ·
- Acceptance to publication 2025
- 8 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | USD 3,250 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted5
- commentaryCommentaryLength not stated
- letter to the editorLetter to the EditorLength not stated
- original researchOriginal ResearchLength not stated
- reviewReviewLength not stated
- short reportShort ReportLength not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Open access policy Model summary
Fatigue: Biomedicine, Health & Behavior is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the dis…
Source ↗Publisher website ·- Peer review Peer Review Integrity
Peer review policy Model summary
All research articles in this journal, including those in special issues, special sections or supplements, undergo rigorous peer review, based on initial editor screening and anonymized refereeing by at least two independent referees.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor & Francis
- ISSN
- 2164-1846
- Electronic ISSN
- 2164-1862
- Society / sponsor
- IACFS/ME
- Latest issue on the website
- Volume 14, Issue 4 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Fatigue-Biomedicine Health and Behavior
What CAS zone is Fatigue-Biomedicine Health and Behavior in?
In the 2025 upgraded edition of the CAS Journal Ranking, Fatigue-Biomedicine Health and Behavior is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Fatigue-Biomedicine Health and Behavior?
The journal's website gives an impact factor of 1.4 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 3.1, h-index 30.
How long does peer review take at Fatigue-Biomedicine Health and Behavior?
Based on the dates recorded on 46 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 119 days (interquartile range 90–168 days); the journal's website gives an acceptance rate of 35% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Fatigue-Biomedicine Health and Behavior based?
Of the 17 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (7), United Kingdom (4) and Australia (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Fatigue-Biomedicine Health and Behavior?
According to LetPub and DOAJ records, Fatigue-Biomedicine Health and Behavior is indexed in ESCI and Scopus.
Is Fatigue-Biomedicine Health and Behavior open access, and what is the APC?
Fatigue-Biomedicine Health and Behavior is a hybrid journal. For open-access publication: APC about USD 3,250.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .